Jazz Pharmaceuticals (JAZZ) Restructuring Costs (2011 - 2018)
Jazz Pharmaceuticals (JAZZ) posted quarterly Restructuring Costs of $44.0 million for Q2 2018, up 307.41% quarter-over-quarter from $10.8 million in Q3 2016.
Jazz Pharmaceuticals (JAZZ) Restructuring Costs (2011 - 2018) Analysis & Trends
Jazz Pharmaceuticals' Restructuring Costs history runs 6 years deep, the most recent figure standing at $44.0 million for Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 44.00 Mn |
| Sep 30, 2016 | 10.80 Mn |
| Jun 30, 2016 | 2.20 Mn |
| Sep 30, 2014 | 700,000.00 |
| Jun 30, 2014 | 4.40 Mn |
| Mar 31, 2014 | 17.10 Mn |
| Jun 30, 2013 | 400,000.00 |
| Jun 30, 2012 | 8.90 Mn |
| Mar 31, 2012 | 3.50 Mn |
| Sep 30, 2011 | 6.00 Mn |